nadira2409
Data înscrierii: 13/Ian/2008 Mesaje: 89 Locație: Bucuresti
|
Trimis: Lun Iun 28, 2010 8:55 pm Titlul subiectului: Osteoporoza:Atentie la FOSFAMAX!! |
|
|
Atentie pt cei care iau Fosfamax pt osteoporoza! medicamentul a pierdut licenta in Sua si firma Merck a fost condamnata sa plateasca daune de 8 mil dolari,s-a confirmat ca medicamentul e periculos poate duce la necroza osoasa din cauza unor defecte de fabricatie si nu e justificata adminstrarea sa in ostepenie. cititi articolul :
The Wall Street Journal (6/26, Bray) reported that Merck & Co. lost a product-liability suit over whether its osteoporosis drug Fosamax (alendronate) caused osteonecrosis.
Bloomberg News (6/25, van Voris, Weidlich) reported, "The jury set damages at $8 million," which was "$3 million more than the $5 million" sought by the plaintiff's lawyers. The case is the first of hundreds of "Fosamax cases, including suits with multiple patients," to go to trial.
"The jury concluded that Fosamax was 'unreasonably dangerous due to defective design, and that its defective design was a legal cause of'" the plaintiff's injury, the AP (6/26, Johnson) reported. Lawyers argued that "evidence showed that Fosamax provides no benefit in preventing bone fractures for women...who did not have osteoporosis." The plaintiff suffered from "osteopenia, a condition in which bone density is beginning to decrease, and Fosamax is approved for preventing fractures in such women." Reuters (6/26) also covered the story.
atamentul. |
|